Impact of the Cu(II) ions on the chemical and biological properties of goserelin - coordination pattern, DNA degradation, oxidative reactivity and in vitro cytotoxicity.

Goserelin acetate (Gos) as a synthetic analog of the mammalian gonadotropin-releasing hormone (GnRH) is widely used in the treatment of sex hormone-related conditions. In this paper we present the chemical and biological aspects of its interaction with Cu(II) ions. The mode of Cu(II) binding and the thermodynamic stability of the obtained complexes were characterized by potentiometry, UV-Vis and CD spectroscopic methods. The DFT calculations were applied in order to investigate and confirm the molecular structure of the studied systems. The experimental and theoretical results clearly indicated the involvement of three nitrogens from the peptide and two oxygens from the acetate moieties in the Cu(II) coordination under physiological conditions. The investigated metallopeptide caused single- and/or double cleavage of the sugar-phosphate backbone of the plasmid DNA in the reaction accompanied by endogenous substances such as hydrogen peroxide or ascorbic acid. The degradation of the DNA molecule occurred via the free radical mechanism. Calculations based on measured spectra allowed determining the kinetic parameters of OH formation. The cytotoxic effects of Gos and its metallo-derivative were tested in vitro towards two cancer cell lines (A549 - human lung adenocarcinoma, CT26 - mouse colon carcinoma).

[1]  R. Martin,et al.  Visible circular dichroism of copper(II) complexes of amino acids and peptides. , 1970, Journal of the American Chemical Society.

[2]  Wan-Xi Yang,et al.  Molecular regulation of hypothalamus-pituitary-gonads axis in males. , 2014, Gene.

[3]  W. Crowley,et al.  The study of GnRH control of reproductive function. , 1984, Upsala journal of medical sciences.

[4]  R. Kühne,et al.  Antagonist and agonist binding models of the human gonadotropin-releasing hormone receptor. , 2005, Biochemical and biophysical research communications.

[5]  K. Goa,et al.  Nafarelin. A review of its pharmacodynamic and pharmacokinetic properties, and clinical potential in sex hormone-related conditions. , 1990, Drugs.

[6]  H. Kozłowski,et al.  2-(Hydroxyimino)propanohydroxamic acid, a new effective ligand for aluminium , 2000 .

[7]  M. Jeżowska‐Bojczuk,et al.  Coordination versatility of phosphine derivatives of fluoroquinolones. New CuI and CuII complexes and their interactions with DNA , 2015 .

[8]  A. Padula GnRH analogues--agonists and antagonists. , 2005, Animal reproduction science.

[9]  A. Kyzioł,et al.  Copper(I) complexes with phosphine derived from sparfloxacin. Part II: a first insight into the cytotoxic action mode. , 2016, Dalton transactions.

[10]  H. Kozłowski,et al.  Coordination ability of the thyrotropin releasing factor. I. Interactions with cupric ions , 1979 .

[11]  I. Voutsadakis,et al.  Hormone Receptors in Serous Ovarian Carcinoma: Prognosis, Pathogenesis, and Treatment Considerations , 2016, Clinical Medicine Insights. Oncology.

[12]  H. Schugar,et al.  Charge-transfer absorptions of copper(II)-imidazole and copper(II)-imidazolate chromophores , 1980 .

[13]  J. Slingerland,et al.  Links between oestrogen receptor activation and proteolysis: relevance to hormone-regulated cancer therapy , 2013, Nature Reviews Cancer.

[14]  A. Albert,et al.  455. The strength of heterocyclic bases , 1948 .

[15]  H. Kozłowski,et al.  Binding of Cu2+, Zn2+, and Ni(2+)-GnRH complexes with the rat pituitary receptor. , 1997, Journal of inorganic biochemistry.

[16]  Rory Stark Differential Oestrogen Receptor Binding is Associated with Clinical Outcome in Breast Cancer , 2012, RECOMB.

[17]  P. Młynarz,et al.  Structural analysis and sheep pituitary receptor binding of GnRH and its complexes with metal ions. , 2003, Journal of inorganic biochemistry.

[18]  B. Halliwell,et al.  Free radicals in biology and medicine , 1985 .

[19]  A. Scozzafava,et al.  A thermodynamic and spectroscopic study of the complexes of the undecapeptide Substance P, of its N-terminal fragment and of model pentapeptides containing two prolyl residues with copper ions , 1991 .

[20]  Helmut Sigel,et al.  Coordinating properties of the amide bond. Stability and structure of metal ion complexes of peptides and related ligands , 1982 .

[21]  H. Kozłowski,et al.  Specific structure–stability relations in metallopeptides , 1999 .

[22]  D. Truhlar,et al.  The M06 suite of density functionals for main group thermochemistry, thermochemical kinetics, noncovalent interactions, excited states, and transition elements: two new functionals and systematic testing of four M06-class functionals and 12 other functionals , 2008 .

[23]  M. Dowsett,et al.  Influence of sex hormones on cancer progression. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  H. Kozłowski,et al.  Further structural analysis of GnRH complexes with metal ions. , 2005, Neuro endocrinology letters.

[25]  P. Leung,et al.  Targeting gonadotropin-releasing hormone receptor inhibits the early step of ovarian cancer metastasis by modulating tumor-mesothelial adhesion. , 2013, Molecular therapy : the journal of the American Society of Gene Therapy.

[26]  M. Tacke,et al.  Bioorganometallic fulvene-derived titanocene anti-cancer drugs. , 2008, Chemical Society reviews.

[27]  H. Schugar,et al.  Electronic spectra of copper(II)-imidazole and copper(II)-pyrazole chromophores , 1981 .

[28]  A. Sharma,et al.  Gonadotropin-releasing hormone analogs: Understanding advantages and limitations , 2014, Journal of human reproductive sciences.

[29]  T. Kiss,et al.  Studies on transition-metal–peptide complexes. Part 12. Copper(II) complexes of dipeptides containing phenylalanine and tyrosine , 1986 .

[30]  Jochen Spiegel,et al.  Azapeptides and their therapeutic potential. , 2011, Future medicinal chemistry.

[31]  H. Kozłowski,et al.  Gonadoliberin (GnRH) and its copper complex (Cu-GnRH) enzymatic degradation in hypothalamic and pituitary tissue in vitro. , 2012, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

[32]  M. Motta,et al.  GnRH receptors in cancer: from cell biology to novel targeted therapeutic strategies. , 2012, Endocrine reviews.

[33]  M. Brattain,et al.  Establishment of Mouse Colonie Carcinoma Cell Lines with Different Metastatic Properties1 , 1980 .

[34]  Leighton J. Core,et al.  A Rapid, Extensive, and Transient Transcriptional Response to Estrogen Signaling in Breast Cancer Cells , 2011, Cell.

[35]  M. Huerta-Reyes,et al.  Human gonadotropin-releasing hormone receptor-activated cellular functions and signaling pathways in extra-pituitary tissues and cancer cells (Review). , 2009, Oncology reports.

[36]  Y. Nishida,et al.  Splitting of d-orbitals in square planar complexes of copper(II), nickel(II) and cobalt(II) , 1979 .

[37]  P. Wise,et al.  The role of the brain in female reproductive aging , 2009, Molecular and Cellular Endocrinology.

[38]  E. H. Strickland,et al.  Aromatic contributions to circular dichroism spectra of proteins. , 1974, CRC critical reviews in biochemistry.

[39]  H. Kozłowski,et al.  How non-bonding amino acid side-chains may enormously increase the stability of a Cu(II)—peptide complex , 1998 .

[40]  Sanford A. Asher,et al.  UV resonance Raman excitation profiles of the aromatic amino acids , 1986 .

[41]  R. Dyball,et al.  Evidence for a direct effect of LRF and TRF on single unit activity in the rostral hypothalamus , 1974, Nature.

[42]  N. C. Price,et al.  How to study proteins by circular dichroism. , 2005, Biochimica et biophysica acta.

[43]  H. Xu,et al.  Androgen receptor: structure, role in prostate cancer and drug discovery , 2014, Acta Pharmacologica Sinica.

[44]  Rory Stark,et al.  Progesterone receptor modulates estrogen receptor-α action in breast cancer , 2015, Nature.

[45]  R. Wieczorek,et al.  Infrared matrix isolation and ab initio studies on isothiocyanic acid HNCS and its complexes with nitrogen and xenon , 2003 .

[46]  T. Plant 60 YEARS OF NEUROENDOCRINOLOGY: The hypothalamo-pituitary-gonadal axis. , 2015, The Journal of endocrinology.

[47]  R. Millar GnRHs and GnRH receptors. , 2005, Animal reproduction science.

[48]  Andreas Zimmer,et al.  A practical note on the use of cytotoxicity assays. , 2005, International journal of pharmaceutics.

[49]  H. Kozłowski,et al.  The impact of the amino-acid sequence on the specificity of copper[II] interactions with peptides having nonco-ordinating side-chains , 1997 .

[50]  A. Mehta,et al.  Engineering metal ion coordination to regulate amyloid fibril assembly and toxicity , 2007, Proceedings of the National Academy of Sciences.

[51]  Paul J Hergenrother,et al.  DNA as a target for anticancer compounds: methods to determine the mode of binding and the mechanism of action. , 2007, Current opinion in biotechnology.

[52]  J. Carroll,et al.  Pioneer factors in hormone-dependent cancers , 2012, Nature Reviews Cancer.

[53]  Z. Latajka,et al.  Ab initio calculations and matrix infrared spectra of the nitrous acid complexes with HF and HCl , 1999 .

[54]  A. Schally,et al.  The identity of chemical and hormonal properties of the thyrotropin releasing hormone and pyroglutamyl-histidyl-proline amide. , 1969, Biochemical and biophysical research communications.

[55]  M. Brattain,et al.  Establishment of mouse colonic carcinoma cell lines with different metastatic properties. , 1980, Cancer research.

[56]  A. Navratil,et al.  Effects of Gonadotrophin‐Releasing Hormone Outside the Hypothalamic‐Pituitary‐Reproductive Axis , 2009, Journal of neuroendocrinology.

[57]  H. Kozłowski,et al.  Metal complexes of luteinizing hormone-releasing hormone (LHRH). potentiometric and spectroscopic studies. , 1988, Journal of inorganic biochemistry.

[58]  L. W. Cheung,et al.  Gonadotropin‐releasing hormone: GnRH receptor signaling in extrapituitary tissues , 2008, The FEBS journal.

[59]  H. Xu Family reunion of nuclear hormone receptors: structures, diseases, and drug discovery , 2015, Acta Pharmacologica Sinica.